EGFR and GNAS mutations were detected exclusively in recurrent tumors (3 of 18 versus 0 of 13), although the difference did not reach statistical significance.
← all excerpts
Genomic and transcriptomic evaluation of primary and recurrent luminal B-like breast cancer.
1
—
—